Irregular sleep and a weaker day-night activity contrast may flag depression relapse weeks before it happens. Could wrist-worn devices become part of relapse prevention?
[read the full story...]
A systematic review of 22 million people finds several mental health conditions, including PTSD, depression and anxiety, are linked to higher acute coronary syndrome risk.
[read the full story...]
The EPISODE trial of psychedelic-assisted therapy for ‘treatment-resistant depression’ finds only modest effects, with a few clear responders, but lingering methodological questions.
[read the full story...]
A single dose of tocilizumab cleared inflammation in depressed patients, but did it ease their symptoms? A proof-of-concept RCT with cautious promise.
[read the full story...]
Psychedelic therapy looks impressive in trials, but when you account for the placebo effect, how does it really compare to antidepressants?
[read the full story...]
Once symptoms stabilise after a first episode of psychosis, should medication continue? A four-year RCT explores the risks and rewards of dose reduction.
[read the full story...]
Four recent reviews all agree: we still don’t know how to define, measure, or improve engagement with digital mental health interventions.
[read the full story...]
Oxytocin alone didn’t speed wound healing in couples, but combined with affectionate touch and partner appreciation, it showed modest benefits. Social context matters more than hormones.
[read the full story...]
Recent research suggests that lower IQ and cognitive performance link to higher alcohol use disorder risk, but education and societal factors can amplify or reduce this vulnerability, not genetics alone.
[read the full story...]
Sexual assault survivors face six-fold increased risk of multiorgan functional somatic disorder (unexplained physical symptoms like chronic pain and fatigue).
[read the full story...]
